(Reuters) - Pfizer Inc (PFE.N) agreed on Wednesday to buy Baxter International Inc's (BAX.N) vaccines unit and a part of a production facility for $635 million.
The deal will give Pfizer access to Baxter's meningitis vaccine, NeisVac-C, and its encephalitis vaccine, FSME-IMMUN.
14:53 Netflix fueled by original programming, even as its costs hold earnings back, analysts say12
21:45 Netflix posts its biggest-ever quarterly subscriber growth, stock surges 8%14
02:14 Green Bay Packers expected to cut Sam Shields20
20:41 Jose Bautista to re-sign with Blue Jays with one-year deal8